Lymphatic deletion of calcitonin receptor-like receptor exacerbates intestinal inflammation

被引:54
|
作者
Davis, Reema B. [1 ]
Kechele, Daniel O. [1 ]
Blakeney, Elizabeth S. [1 ]
Pawlak, John B. [1 ]
Caron, Kathleen M. [1 ]
机构
[1] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA
来源
JCI INSIGHT | 2017年 / 2卷 / 06期
关键词
CROHNS-DISEASE; VASCULAR DEVELOPMENT; HYDROPS-FETALIS; VESSEL DENSITY; BOWEL-DISEASE; MICE LACKING; VEGF-C; ADRENOMEDULLIN; DIFFERENTIATION; INDOMETHACIN;
D O I
10.1172/jci.insight.92465
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lymphatics play a critical role in maintaining gastrointestinal homeostasis and in the absorption of dietary lipids, yet their roles in intestinal inflammation remain elusive. Given the increasing prevalence of inflammatory bowel disease, we investigated whether lymphatic vessels contribute to, or may be causative of, disease progression. We generated a mouse model with temporal and spatial deletion of the key lymphangiogenic receptor for the adrenomedullin peptide, calcitonin receptor-like receptor (Calcrl), and found that the loss of lymphatic Calcrl was sufficient to induce intestinal lymphangiectasia, characterized by dilated lacteals and protein-losing enteropathy. Upon indomethacin challenge, Calcrl(fl/fl)/Prox1-CreER(T2) mice demonstrated persistent inflammation and failure to recover and thrive. The epithelium and crypts of Calcrl(fl/fl)/Prox1-CreER(T2) mice exhibited exacerbated hallmarks of disease progression, and the lacteals demonstrated an inability to absorb lipids. Furthermore, we identified Calcrl/adrenomedullin signaling as an essential upstream regulator of the Notch pathway, previously shown to be critical for intestinal lacteal maintenance and junctional integrity. In conclusion, lymphatic insufficiency and lymphangiectasia caused by loss of lymphatic Calcrl exacerbates intestinal recovery following mucosal injury and underscores the importance of lymphatic function in promoting recovery from intestinal inflammation.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Deletion of Transferrin Receptor 2 Exacerbates Intestinal Inflammation and Bone Loss during Experimental Colitis in Mice
    Colunga, Maria G. Ledesma
    Passin, Vanessa
    Weidner, Heike
    Hofbauer, Lorenz C.
    Rauner, Martina
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 273 - 273
  • [32] Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes
    Roh, J
    Chang, CL
    Bhalla, A
    Klein, C
    Hsu, SYT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) : 7264 - 7274
  • [33] The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function
    Fitzsimmons, TJ
    Zhao, XL
    Wank, SA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 14313 - 14320
  • [34] Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling
    Kuwasako, K
    Shimekake, Y
    Masuda, M
    Nakahara, K
    Yoshida, T
    Kitaura, M
    Kitamura, K
    Eto, T
    Sakata, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) : 29602 - 29609
  • [35] Calcitonin receptor-like receptor (CLR) influences posttranslational events of receptor activity-modifying proteins (RAMPs)
    Nag, Kakon
    Sultana, Naznin
    Hirose, Shigehisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 418 (04) : 824 - 829
  • [36] Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature
    Oliver, KR
    Wainwright, A
    Edvinsson, L
    Pickard, JD
    Hill, RG
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (05): : 620 - 629
  • [37] Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1
    Cottrell, Graeme S.
    Padilla, Benjamin
    Pikios, Stella
    Roosterman, Dirk
    Steinhoff, Martin
    Grady, Eileen F.
    Bunnett, Nigel W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (16) : 12260 - 12271
  • [38] The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
    Linus Angenendt
    Eike Bormann
    Caroline Pabst
    Vijay Alla
    Dennis Görlich
    Leonie Braun
    Kim Dohlich
    Christian Schwöppe
    Stefan K. Bohlander
    Maria Francisca Arteaga
    Klaus Wethmar
    Wolfgang Hartmann
    Adrian Angenendt
    Torsten Kessler
    Rolf M. Mesters
    Matthias Stelljes
    Maja Rothenberg-Thurley
    Karsten Spiekermann
    Josée Hébert
    Guy Sauvageau
    Peter J. M. Valk
    Bob Löwenberg
    Hubert Serve
    Carsten Müller-Tidow
    Georg Lenz
    Bernhard J. Wörmann
    M. Christina Sauerland
    Wolfgang Hiddemann
    Wolfgang E. Berdel
    Utz Krug
    Klaus H. Metzeler
    Jan-Henrik Mikesch
    Tobias Herold
    Christoph Schliemann
    Leukemia, 2019, 33 : 2830 - 2841
  • [39] The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling
    Kuwasako, Kenji
    Hay, Debbie L.
    Nagata, Sayaka
    Hikosaka, Tomomi
    Kitamura, Kazuo
    Kato, Johji
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (01) : 137 - 150
  • [40] The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
    Angenendt, Linus
    Bormann, Eike
    Pabst, Caroline
    Alla, Vijay
    Goerlich, Dennis
    Braun, Leonie
    Dohlich, Kim
    Schwoeppe, Christian
    Bohlander, Stefan K.
    Arteaga, Maria Francisca
    Wethmar, Klaus
    Hartmann, Wolfgang
    Angenendt, Adrian
    Kessler, Torsten
    Mesters, Rolf M.
    Stelljes, Matthias
    Rothenberg-Thurley, Maja
    Spiekermann, Karsten
    Hebert, Josee
    Sauvageau, Guy
    Valk, Peter J. M.
    Loewenberg, Bob
    Serve, Hubert
    Mueller-Tidow, Carsten
    Lenz, Georg
    Woermann, Bernhard J.
    Sauerland, M. Christina
    Hiddemann, Wolfgang
    Berdel, Wolfgang E.
    Krug, Utz
    Metzeler, Klaus H.
    Mikesch, Jan-Henrik
    Herold, Tobias
    Schliemann, Christoph
    LEUKEMIA, 2019, 33 (12) : 2830 - 2841